Pharma Mar, S.A. (BME:PHM)
86.80
-1.05 (-1.20%)
Sep 25, 2025, 5:35 PM CET
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.51 billion as of September 25, 2025. Its market cap has increased by 100.46% in one year.
Market Cap
1.51B
Enterprise Value
1.43B
Revenue
189.27M
Ranking
n/a
PE Ratio
35.85
Stock Price
€86.80
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.51B, a decrease of -16.28%. That is a compound annual growth rate of -1.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 25, 2025 | 1.51B | 8.44% |
Dec 31, 2024 | 1.39B | 88.09% |
Dec 29, 2023 | 738.49M | -36.23% |
Dec 30, 2022 | 1.16B | 12.13% |
Dec 30, 2021 | 1.03B | -21.36% |
Dec 31, 2020 | 1.31B | 66.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Nov 2, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grifols | 7.35B |
Laboratorios Farmaceuticos Rovi | 2.97B |
Almirall | 2.47B |
Faes Farma | 1.31B |
Clínica Baviera | 693.45M |
Oryzon Genomics | 261.00M |
Laboratorio Reig Jofre | 229.52M |
Prim, S.A. | 228.87M |